Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Free cash flow margin
Solventum Corporation's free cash flow margin over the twelve months to 30 June 2026 was −1.42%, down 1.3 percentage points from fiscal 2025 (−0.12%). That is below the Medical Instruments & Supplies industry median of 1.08% and below the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | −0.12% | (9.87) |
| FY2024 | 9.75% | (10.07) |
| FY2023 | 19.8% | 2.26 |
| FY2022 | 17.6% | — |
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| ALGN Align Technology, Inc. compare | 16.3% |
| COO The Cooper Companies, Inc. compare | 16.0% |
| ALC Alcon compare | 14.7% |
| RGEN Repligen Corporation compare | 14.1% |
| WST West Pharmaceutical Services, Inc. compare | 13.1% |
| ATR AptarGroup, Inc. compare | 8.00% |
| BAX Baxter International Inc. compare | 7.11% |
| AVTR Avantor, Inc. compare | 6.93% |
| SOLV Solventum Corporation | −1.42% |
| Medical Instruments & Supplies industry median | 1.08% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement